Evidence map›Paper›PMID 32714589›Full record

ArticleNeuronal signaling2018

A novel variant in

Sarah E Hurst, Erika Liktor-Busa, Aubin Moutal, Sara Parker, Sydney Rice, Szabolcs Szelinger, Grant Senner, Michael F Hammer, Laurel Johnstone, Keri Ramsey and 9 more

Open access · goldAbstract read
In one paragraph

Article in Neuronal signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. The roles of TAF1 in neuroscience and beyond.Royal Society open science · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X-linked Dystonia-Parkinsonism.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. X-Linked Dystonia-Parkinsonism: recent advances.Current opinion in neurology · 2019
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Sarah E HurstDepartment of Pathology, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
Erika Liktor-BusaDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
Aubin MoutalDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
Sara ParkerDepartment of Cellular and Molecular Medicine, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
Sydney RiceDepartment of Pediatrics, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
Szabolcs SzelingerCenter for Rare Childhood Disorders, The Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, U.S.A.
Grant SennerDepartment of Family and Community Medicine, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
Michael F HammerArizona Research Laboratories Division of Biotechnology, University of Arizona, Tucson, AZ 85721, U.S.A.
Laurel JohnstoneArizona Research Laboratories Division of Biotechnology, University of Arizona, Tucson, AZ 85721, U.S.A.
Keri RamseyCenter for Rare Childhood Disorders, The Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, U.S.A.
Vinodh NarayananCenter for Rare Childhood Disorders, The Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, U.S.A.
Samantha Perez-MillerDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
May KhannaDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
Heather DahlinDepartment of Pharmacology, University of Washington, School of Medicine Seattle, WA 98195, U.S.A.
Karen LewisDepartment of Pharmacology, University of Washington, School of Medicine Seattle, WA 98195, U.S.A.
David CraigCenter for Rare Childhood Disorders, The Translational Genomics Research Institute (TGen), Phoenix, AZ 85004, U.S.A.
Edith H WangDepartment of Pharmacology, University of Washington, School of Medicine Seattle, WA 98195, U.S.A.
Rajesh KhannaDepartment of Pharmacology, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
Mark A NelsonDepartment of Pathology, University of Arizona College of Medicine, Tucson, AZ 85724, U.S.A.
University of Arizona · USTranslational Genomics Research Institute · USUniversity of Washington · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the genome of a 5-year-old male who presented with global developmental delay (motor, cognitive, and speech), hypotonia, possibly ataxia, and cerebellar hypoplasia of unknown origin. Whole genome sequencing (WGS) and mRNA sequencing (RNA-seq) were performed on a family having an affected proband, his unaffected parents, and maternal grandfather. To explore the molecular and functional consequences of the variant, we performed cell proliferation assays, quantitative real-time PCR (qRT-PCR) array, immunoblotting, calcium imaging, and neurite outgrowth experiments in SH-SY5Y neuroblastoma cells to compare the properties of the wild-type TATA-box-binding protein factor 1 (

Indexed as

CACNA1Gcyclin D1RNA sequencingTAF-1whole genome sequencingX-chromosome inactivation

Identifiers

PMID32714589
PMCPMC7373232
OpenAlexW2810257747

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.